A Study of Subcutaneously Administered RO7845860 in Participants With Relapsing Multiple Sclerosis

NCT07749157 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
85
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche